Literature DB >> 21671822

The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer.

Adam Daragó1, Andrzej Sapota, Józef Matych, Marzenna Nasiadek, Małgorzata Skrzypińska-Gawrysiak, Anna Kilanowicz.   

Abstract

BACKGROUND: The objective of the present study is to explore the association between zinc concentrations and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and total prostate-specific antigen (tPSA) levels in the serum of patients with prostate cancer (PCa) and prostate intraepithelial neoplasia (PIN), a pre-cancer state matched for age.
METHODS: The study was carried out in a group of 229 patients who had transurethral prostate biopsy performed. The patients were divided into three groups: control group (BPH), PIN group or PCa group. The patients had plasma zinc concentration determined by atomic absorption spectrometry; IGF-1, IGFBP-3 analyzed using the chemiluminescence method and tPSA detected in serum with DELFIA assay.
RESULTS: The studies revealed that, in PCa and PIN patients aged under 65 years, mean zinc concentrations were significantly lower compared with the control group. IGF-1 level significantly increased with decreasing level of zinc in plasma, hence a significantly decreased Zn/IGF-1 ratio. The mean tPSA concentration was significantly increased only in PCa patients of both age groups, whereas the Zn/tPSA ratio significantly decreased with increasing severity of neoplastic lesions, particularly in patients aged under 65 years. Statistical significance was noted for IGF-1:tPSA and IGFBP-3:tPSA ratios, being almost two-fold lower in the PCa patients than in the control group.
CONCLUSIONS: A significantly lowered Zn/tPSA ratio appears to be a sensitive marker of neoplastic lesions, PCa and PIN, regardless of age. In men under 65 years, the Zn/IGF-1 ratio was reduced, depending on the stage of neoplastic lesions (PIN>PCa). These finding can be useful in early diagnosis of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671822     DOI: 10.1515/CCLM.2011.651

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  9 in total

Review 1.  Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis.

Authors:  Jiang Zhao; Qingjian Wu; Xiaoyan Hu; Xingyou Dong; Liang Wang; Qian Liu; Zhou Long; Longkun Li
Journal:  Sci Rep       Date:  2016-05-12       Impact factor: 4.379

Review 2.  Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.

Authors:  Sean Harrison; Rosie Lennon; Jeff Holly; Julian P T Higgins; Mike Gardner; Claire Perks; Tom Gaunt; Vanessa Tan; Cath Borwick; Pauline Emmet; Mona Jeffreys; Kate Northstone; Sabina Rinaldi; Stephen Thomas; Suzanne D Turner; Anna Pease; Vicky Vilenchick; Richard M Martin; Sarah J Lewis
Journal:  Cancer Causes Control       Date:  2017-03-30       Impact factor: 2.506

3.  Effects of insulin-like growth factor binding protein 3 on apoptosis of cutaneous squamous cell carcinoma cells.

Authors:  Jinli Liu; Yuanyuan Guo; Yuanyuna Huang; Haowei Xue; Suwen Bai; Jinhang Zhu; Xianming Xia; Bing Shen; Wei Fang
Journal:  Onco Targets Ther       Date:  2018-10-05       Impact factor: 4.147

4.  Effects of Dietary or Supplementary Micronutrients on Sex Hormones and IGF-1 in Middle and Older Age: A Systematic Review and Meta-Analysis.

Authors:  Ryan Janjuha; Diane Bunn; Richard Hayhoe; Lee Hooper; Asmaa Abdelhamid; Shaan Mahmood; Joseph Hayden-Case; Will Appleyard; Sophie Morris; Ailsa Welch
Journal:  Nutrients       Date:  2020-05-18       Impact factor: 5.717

Review 5.  Current opinion on the role of testosterone in the development of prostate cancer: a dynamic model.

Authors:  Xiaohui Xu; Xinguang Chen; Hui Hu; Amy B Dailey; Brandie D Taylor
Journal:  BMC Cancer       Date:  2015-10-26       Impact factor: 4.430

6.  Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.

Authors:  Jian Qian; Hai Zhou; Jiawei Chen; Qi Ding; Qiang Cao; Chao Qin; Pengfei Shao; Pu Li; Hongzhou Cai; Xiaoxin Meng; Xiaobing Ju; Meilin Wang; Zhengdong Zhang; Jie Li; Lixin Hua; Changjun Yin
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

7.  Serum and tissue zinc in epithelial malignancies: a meta-analysis.

Authors:  Jaromir Gumulec; Michal Masarik; Vojtech Adam; Tomas Eckschlager; Ivo Provaznik; Rene Kizek
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

8.  Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.

Authors:  Katarzyna Białkowska; Wojciech Marciniak; Magdalena Muszyńska; Piotr Baszuk; Satish Gupta; Katarzyna Jaworska-Bieniek; Grzegorz Sukiennicki; Katarzyna Durda; Tomasz Gromowski; Karolina Prajzendanc; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Tadeusz Dębniak; Rodney J Scott; Jan Lubiński; Anna Jakubowska
Journal:  PLoS One       Date:  2018-07-23       Impact factor: 3.240

Review 9.  Advances of Zinc Signaling Studies in Prostate Cancer.

Authors:  Dangdang Li; Daniel B Stovall; Wenmeng Wang; Guangchao Sui
Journal:  Int J Mol Sci       Date:  2020-01-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.